160806-40-6

Basic information

• Product Name: 2-Pyrrolidinone,4-amino-,(4S)-(9CI)
• Synonyms: 2-Pyrrolidinone,4-amino-,(4S)-(9CI);(S)-4-aminopyrrolidin-2-one;(S)-4-amino-2-Pyrrolidinone;(4S)-4-aMino-2-Pyrrolidinone;(4S)-4-Aminopyrrolidin-2-one;2-Pyrrolidinone,4-aMino-, (4S)-;4(S)-Amino-2-pyrrolidinone
• CAS NO: 160806-40-6
• Molecular Formula: C₄H₈N₂O
• Molecular Weight: 100.12
• Product Categories: VARIOUSAMINE
• Mol File: 160806-40-6.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 305.6±35.0 °C(Predicted)
• Appearance: /
• Density: 1.127
• Storage Temp.: 2-8°C
• PKA: 15.92±0.40(Predicted)
• CAS DataBase Reference: 2-Pyrrolidinone,4-amino-,(4S)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrrolidinone,4-amino-,(4S)-(9CI)(160806-40-6)
• EPA Substance Registry System: 2-Pyrrolidinone,4-amino-,(4S)-(9CI)(160806-40-6)

Safety Data

• Hazardous Substances Data: 160806-40-6(Hazardous Substances Data)

Usage

General Description

2-Pyrrolidinone, 4-amino, (4S)-(9CI) is a chemical compound with the molecular formula C4H8N2O. It is a cyclic amide with a pyrrolidine ring and an amino group attached to the fourth position. 2-Pyrrolidinone,4-amino-,(4S)-(9CI) has potential applications in the pharmaceutical and chemical industries, as it can function as a versatile building block for the synthesis of various pharmaceutical drugs and organic compounds. Additionally, it may possess biological activity and could be used as a precursor for the production of other valuable chemicals. The stereochemistry of 4S indicates the specific orientation of the chemical groups in the molecule, which is important for understanding its reactivity and potential applications. Overall, 2-Pyrrolidinone, 4-amino, (4S)-(9CI) is a valuable compound with potential uses in various fields.

Upstream product

• 899806-32-7 (S)-4-azidopyrrolidin-2-one 

Relevant articles and documents

HALOARYL SUBSTITUTED AMINOPURINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are Aminopurine Compounds having the following structure: (I) wherein R1 , R2 and and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.